Dysmyelination induced in vitro by IgM antisulfatide and antigalactocerebroside monoclonal antibodies

Journal of Neuroscience Research

Volumn 71, Issue 1, 2003, Pages 104-109

  Rosenbluth, Jack ^a   Moon, David ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Demyelination; Multiple sclerosis; Neuropathy; Paraproteinemia

Indexed keywords

GALACTOSYLCERAMIDE; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; MYELIN; SULFATIDE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; HYBRIDOMA CELL CULTURE; IN VITRO STUDY; LAMELLAR BODY; MACROPHAGE; MULTIPLE SCLEROSIS; MYELIN DEFICIENCY; NEUROPATHY; NONHUMAN; PARAPROTEINEMIA; PATHOGENESIS; PRIORITY JOURNAL; SCHWANN CELL; SPINAL GANGLION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DEMYELINATING DISEASES; GALACTOSYLCERAMIDES; GANGLIA, SPINAL; HYBRIDOMAS; IMMUNOGLOBULIN M; MICROSCOPY, ELECTRON; MYELIN SHEATH; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SCHWANN CELLS; SULFOGLYCOSPHINGOLIPIDS; TIME FACTORS;

EID: 0037214471     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10448     Document Type: Article

References (21)

1. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. 1989. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
2. Bunge RP, Bunge MB, Bates M. 1989. Movements of the Schwann cell nucleus implicate progress of the inner (axon-related) Schwann cell process during myelination. J Cell Biol 109:273-284.
3. Einheber S, Milner TA, Giancotti F, Salzer JL. 1993. Axonal regulation of Schwann cell integrin expression suggests a role for α6β4 in myelination. J Cell Biol 123:1223-1236.
4. Jacobs JM, Scadding JW. 1990. Morphological changes in IgM paraproteinemic neuropathy. Acta Neuropath (Berl) 80:77-84.
5. Kleitman N, Wood PM, Bunge RP. 1998. Tissue culture methods for the study of myelination. In: Banker G, Goslin K, editors. Culturing Nerve Cells, 2nd Ed. Cambridge: MIT Press. p 546-599.
6. Latov N. 1994. Antibodies to glycoconjugates in neuropathy and motor neuron disease. Prog Brain Res 101:295-303.
7. Latov N. 1995. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol 37:S32-42.
8. Metzger H. 1970. Structure and function of γM macroglobulins. Adv Immunol 12:57-116.
9. Peters A, Palay SL, Webster H. 1991. The Fine Structure of the Nervous System. Third Ed. New York: Oxford.
10. Prineas JW. 1985. The neuropathology of multiple sclerosis. In: Koester JC, editor. Handbook of Clinical Neurology. Vol 3. Demyelinating Diseases. New York: Elsevier. p 213-257.
11. Raine CS, Bornstein MB. 1979. Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures. Lab Invest 40:423-432.
12. Raine CS, Diaz M, Pakingan M, Bornstein MB. 1978. Antiserum-induced dissociation of myelinogenesis in vitro: An ultrastructural study. Lab Invest 38:397-403.
13. Raine CS, Johnson AB, Marcus DM, Suzuki A, Bornstein MB. 1981. Demyelination in vitro: Absorption studies demonstrate that galactocerebroside is a major target. J Neurol Sci 52:117-131.
14. Ranscht B, Wood PL, Bunge RP. 1987. Inhibition of in vitro peripheral myelin formation by monoclonal antigalactocerebroside. J Neurosci 7:2936-2947.
15. Revel JP, Hamilton DW. 1969. The double nature of the intermediate dense line in the peripheral nerve myelin. Anat Rec 163:7-16.
16. Robertson JD. 1958. Structural alterations in nerve fibers produced by hypotonic and hypertonic solutions. J Biophys Biochem Cytol 4:349-364.
17. Rosenbluth J, Liang WL, Schiff R, Dou WK. 1997. Spinal cord dysmyelination induced in vivo by IgM antibodies to three different myelin glycolipids. Glia 19:58-66.
18. Rosenbluth J, Liu Z, Guo D, Schiff R. 1994. Inhibition of CNS myelin development in vivo by implantation of anti-GalC hybridoma cells. J Neurocytol 23:699-707.
19. Rosenbluth J, Liang WL, Liu Z, Guo D, Schiff R. 1995. Paranodal structural abnormalities in rat CNS myelin developing in vivo in the presence of implanted O1 hybridoma cells. J Neurocytol 24:818-824.
20. Rosenbluth J, Liang WL, Liu Z, Guo D, Schiff R. 1996. Expanded CNS myelin sheaths formed in situ in the presence of an IgM antigalactocerebroside-producing hybridoma. J Neurosci 16:2635-2641.
21. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.